RxSight (RXST) Other Non-Current Assets (2020 - 2026)
RxSight's (RXST) quarterly Other Non-Current Assets came in at $1.0 million in Q1 2026, up 36.8% YoY from $750000.0 in Q1 2025, and up 36.8% on a QoQ basis from $750000.0 in Q4 2025.
RxSight (RXST) Other Non-Current Assets (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Other Non-Current Assets data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 36.8% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 36.8% YoY) and the FY2025 annual result came in at $750000.0, up 108.33% from the prior year.
- Other Non-Current Assets advanced to $1.0 million in Q1 2026, from $750000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q1 2026 to a low of $188000.0 in Q2 2022.
- A 5-year average of $613764.7 and a median of $711000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 86.01% — and 2025, when it soared 251.17%.
- Tracing RXST's Other Non-Current Assets over 5 years: stood at $767000.0 in 2022, then retreated by 7.3% to $711000.0 in 2023, then sank by 49.37% to $360000.0 in 2024, then jumped by 108.33% to $750000.0 in 2025, then jumped by 36.8% to $1.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.0 million (Q1 2026), $750000.0 (Q4 2025), and $748000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | 542,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 711,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 711,000.00 |
| Sep 30, 2023 | 711,000.00 |
| Jun 30, 2023 | 348,000.00 |
| Mar 31, 2023 | 761,000.00 |
| Dec 31, 2022 | 767,000.00 |
| Sep 30, 2022 | 811,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 811,000.00 |
| Dec 31, 2021 | 811,000.00 |
| Sep 30, 2021 | 287,000.00 |